Biotechnology Marketing

Biotechnology Healthcare

2009-10-28T21:39:00.000-07:00

Biotechnology Healthcare

The threat of new epidemics have encouraged the development of biological vaccines that promise dramatic improvements in health globally and locally. Several susceptible to prevention or treatment of chronic diseases. But uncertainties, including immunization raise the question whether the system of health care products promising to make this viable.

Today's challenges.

Once regarded as a chronic disease, Kaposi's sarcoma, Helicobacter pylori gastric ulcers and cancer of the cervix, among others, are now regarded as infectious diseases - and the trend seems to be reclassified chronic diseases, but more infectious. The current vaccines are either prophylactic or therapeutic. And whether a vaccine can actually be called therapy - a subject of contention among many researchers of diseases such terms are increasingly used to distinguish between, say, a vaccine against influenza and treatment of cancer.

Pharmaceuticals Marketing

2009-10-28T21:34:00.000-07:00

Generic Marketing

2009-10-28T21:31:00.000-07:00

Biotech News

2009-10-28T21:29:00.000-07:00

Biotechnology Degree

2009-10-28T21:10:00.000-07:00

Biotechnology Product

2009-10-28T04:39:00.000-07:00

Biotechnology Product.

There are more than 90 biotechnology products existing in the world today, including drugs and vaccines approved by the Food U. S. and Drug Administration (FDA). Otherwise, research and development remains strong, with more than 350 biotechnology drugs and vaccines are still in human clinical trials. They give hope to suffering from many incurable diseases afflicting the population and irrepressible, like cancer, AIDS, Alzheimer's, diabetes, multiple sclerosis and other serious illnesses.

We see major improvements in medical progress, but we must also take into account the remarkable progress in agriculture, the use of biopesticides hazardous effects of pesticides to the environment and cultures and the many ways Biotechnology has helped in the fields of pharmaceuticals and chemicals, energy and environmental management.

Biotechnology is also a lucrative market, as biotech companies and biotech industries to generate revenue in the region of 50 billion U.S. dollars per year.